Headquartered in Vancouver, British Columbia, Canada, CDRD is Canada’s national life sciences venture, powering the country’s life sciences industry by creating and growing companies of scale – and training the scientific and business talent needed to drive them to become leading global anchors in Canada.
We build collaborations with the very best partners from academia, industry, patient foundations, the investment community, and other Key Opinion Leaders to provide the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector — and ultimately into new therapies for patients.
CDRD is a catalyst for Canadian life sciences leading the world.
- Be a global bridge that translates discoveries into innovative therapeutic products & improved health outcomes
- Build sustainable partnerships to identify & advance promising discoveries & transform them into validated investments
- Uniquely train the next generation of highly-qualified personnel to drive the development of innovations
CDRD was founded in 2007, enabled by the support of the federal government (most notably through the Centres of Excellence for Commercialization and Research (CECR) program), the BC provincial government, and the private sector. Now with a proven track record of results, CDRD is firmly positioned as a central leader in Canada’s innovation ecosystem.
CDRD has amassed strategic partnerships with over 50 affiliated universities and research institutes, 26 Canadian health sciences SMEs/entrepreneurs, six top global pharmaceutical companies, eight of the world’s leading translational research centres, and three patient-focused foundations. Through this extensive network and relationships with the most influential Key Opinion Leaders, decision makers, and supporters shaping Canadian and global innovation, CDRD brings together the complementary expertise and resources required to proactively find and evaluate, and then collaboratively develop and commercialize the most therapeutically and commercially promising technologies. These are disruptive, game-changing technologies not only for patients, but for the critical mass of strong new Canadian health sciences anchor companies that are being built upon them.